MCQ Detailed View

HMPV stands for Human Metapneumovirus. It is a respiratory virus that belongs to the family Pneumoviridae and is closely related to the Respiratory Syncytial Virus (RSV). HMPV was first discovered in 2001 in the Netherlands, but further research revealed that it had been circulating in humans for decades.

Human Metapneumovirus is an important cause of respiratory tract infections in people of all age groups, but it most commonly affects infants, young children, elderly individuals, and those with weakened immune systems. The virus spreads through respiratory droplets when an infected person coughs or sneezes, or through contact with contaminated surfaces.

HMPV primarily causes symptoms similar to those of the common cold, including cough, nasal congestion, fever, sore throat, and sometimes wheezing. In more severe cases, it can lead to bronchitis or pneumonia, particularly in vulnerable populations.

Unlike Mycoplasma, which refers to a different type of bacteria, HMPV is a virus. It cannot be treated with antibiotics. There is no specific antiviral treatment for HMPV; most cases are mild and recover with supportive care such as rest, fluids, and fever reducers.

It is important not to confuse HMPV with similar-sounding terms such as “Human Mycoplasma Virus” or “Human Molecular Virus,” which do not accurately describe this respiratory pathogen.

In biological terms, HMPV is a significant topic in the study of virology and human disease. Understanding viruses like HMPV is essential for studying the human immune system, infection control, and disease prevention.